No Data
No Data
China Resources Double-Crane Pharmaceutical Plans Up to 500-Million-Yuan Investment in Financial Products
Zhuzhou Tianqiao Crane Co., Ltd.'s (SZSE:002523) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
CR Double-Crane Pharma Gets Europe's Suitability Certificate for Dienogest
Express News | U.S. Justice Department Says Crane Company Manitowoc to Pay $42.6M for Clean Air Act Violations for Sale of Noncompliant Diesel Engines in Heavy Duty Cranes
Moody's Upgrades National Bank of Canada Long-term Ratings, Ending Review for Upgrade
D.A. Davidson Maintains Crane(CR.US) With Buy Rating, Announces Target Price $185